Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
暂无分享,去创建一个
F. Breedveld | T. Huizinga | R. Toes | W. V. van Venrooij | E. Zanelli | R. de Vries | Tom W J Huizinga | Ferdinand C Breedveld | C. Verweij | F. V. van Gaalen | Geziena M Th Schreuder | Cornelis L Verweij | Walther J van Venrooij | René E M Toes | Floris A van Gaalen | Jill van Aken | Eric Zanelli | René R P de Vries | G. Schreuder | J. van Aken
[1] M. V. van Leeuwen,et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. , 2000, Arthritis and rheumatism.
[2] Wendy Thomson,et al. Relationship among the HLA-DRB1 shared epitope, smoking, and rheumatoid factor production in rheumatoid arthritis. , 2002, Arthritis and rheumatism.
[3] P. Gregersen,et al. The genetics revolution and the assault on rheumatoid arthritis. , 1999, Arthritis and rheumatism.
[4] Koen Vos,et al. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. , 2002, Arthritis and rheumatism.
[5] A. Zwinderman,et al. Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage. , 2002, Arthritis and rheumatism.
[6] E. Girbal-Neuhauser,et al. In the rheumatoid pannus, anti‐filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum , 2000, Clinical and experimental immunology.
[7] F. Breedveld,et al. An extended HLA-DQ-DR haplotype rather than DRB1 alone contributes to RA predisposition , 1998, Immunogenetics.
[8] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[9] D. M. van der Heijde,et al. The course of radiologic damage during the first six years of rheumatoid arthritis. , 2000, Arthritis and rheumatism.
[10] N. de Vries,et al. Reshaping the shared epitope hypothesis: HLA-associated risk for rheumatoid arthritis is encoded by amino acid substitutions at positions 67-74 of the HLA-DRB1 molecule. , 2002, Arthritis and rheumatism.
[11] M. V. van Boekel,et al. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value , 2001, Arthritis research.
[12] Filip De Keyser,et al. Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: Relevance to antifilaggrin autoantibodies , 2001 .
[13] F. V. D. van den Hoogen,et al. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. , 1998, The Journal of clinical investigation.
[14] A. Zwinderman,et al. Human leukocyte antigen-DQ and DR polymorphisms predict rheumatoid arthritis outcome better than DR alone. , 2001, Human immunology.
[15] F. Breedveld,et al. Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care. , 1998, British journal of rheumatology.
[16] C. Deighton,et al. The contribution of H LA to rheumatoid arthritis , 1989 .
[17] P. Schur. IgG subclasses--a review. , 1987, Annals of allergy.
[18] S. Cessie,et al. Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis , 2004, Annals of the rheumatic diseases.
[19] J. Hazes,et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. , 2000, Arthritis and rheumatism.
[20] J. Hazes,et al. HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis. , 1999, Human immunology.
[21] F. Arnett. Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.
[22] D. F. Roberts,et al. The contribution of HLA to rheumatoid arthritis. , 1989, Clinical genetics.
[23] Göran Hallmans,et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. , 2003, Arthritis and rheumatism.
[24] E. Vossenaar,et al. Anti-CCP antibodies, a highly specific marker for (early) rheumatoid arthritis , 2004 .
[25] H. Schumacher,et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset , 2000, Arthritis research.
[26] T. Perneger,et al. Association of rheumatoid factors and anti-filaggrin antibodies with severity of erosions in rheumatoid arthritis. , 2000, Rheumatology.
[27] Désirée van der Heijde,et al. Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability. , 1996 .
[28] U. Wagner,et al. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis. , 1997, Arthritis and rheumatism.
[29] J. Hazes,et al. Diagnostic and prognostic characteristics of the enzyme linked immunosorbent rheumatoid factor assays in rheumatoid arthritis. , 1996, Annals of the rheumatic diseases.
[30] A. Zwinderman,et al. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study. , 1991, Arthritis and rheumatism.
[31] M. González-Gay,et al. Could HLA-DRB1 be the protective locus in rheumatoid arthritis? , 1995, Immunology today.
[32] F. Breedveld,et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. , 2004, Arthritis and rheumatism.
[33] P. Tiberghien,et al. Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis. , 2001, Arthritis and rheumatism.
[34] P. Gregersen,et al. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. , 1987, Arthritis and rheumatism.
[35] E. Girbal-Neuhauser,et al. The Major Synovial Targets of the Rheumatoid Arthritis-Specific Antifilaggrin Autoantibodies Are Deiminated Forms of the α- and β-Chains of Fibrin1 , 2001, The Journal of Immunology.
[36] R. Winchester. The molecular basis of susceptibility to rheumatoid arthritis. , 1994, Advances in immunology.
[37] Yusuke Nakamura,et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis , 2003, Nature Genetics.
[38] A. Sette,et al. Cutting Edge: The Conversion of Arginine to Citrulline Allows for a High-Affinity Peptide Interaction with the Rheumatoid Arthritis-Associated HLA-DRB1*0401 MHC Class II Molecule1 , 2003, The Journal of Immunology.